Congressional op-ed about the LTA!
We are closing in on nearly 2,000 email letters to Congress this week! If you haven’t sent yours yet, please click here to email your Representative and Senators – simply fill in
We are closing in on nearly 2,000 email letters to Congress this week! If you haven’t sent yours yet, please click here to email your Representative and Senators – simply fill in
The next few weeks will determine if the LTA is passed this year, before the end of the current Congress, and that’s why your participation in every call to action
It’s crunch time! The next few weeks will determine if the Lymphedema Treatment Act is passed during this Congress. Each week we will be issuing at least one call to action,
Can you contribute $20, or whatever is right for your budget, so that we can wrap up our Match 2020campaign this week? The amount doesn’t matter, but your support does, and
Regardless of the outcome of today’s election, the current Congress continues through the end of the year. Meaning, the next two month are critically important to us! It’s no secret that
The Lymphedema Advocacy Group is proud to be a finalist for a 2020 RareVoice Award. We are thrilled and honored that our work to improve insurance coverage for lymphedema compression supplies is being showcased!
As a resource to the lymphedema community, this year anyone can attend the virtual exhibit hall at the National Lymphedema Network’s online conference!The Lymphedma Advocacy Group is one of dozens
We are in the final months of this Congress and need your support to be able to do everything possible to get the Lymphedema Treatment Act signed into law this year!
In recognition of October’s Breast Cancer Awareness Month, the Lymphedema Advocacy Group issued the following press release about the importance of passing the Lymphedema Treatment Act. If you have any contacts
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

